Ewa, LLC Tiziana Life Sciences LTD Transaction History

Ewa, LLC

$266 Billion
Q4 2024

A detailed history of Ewa, LLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Ewa, LLC holds 50,108 shares of TLSA stock, worth $71,654. This represents 0.01% of its overall portfolio holdings.

Number of Shares

50,108

Previous 50,584 0.94%

Holding current value

$71,654

Previous $46.8 Million 25.39%

% of portfolio

0.01%

Previous 0.02%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.67 - $1.18 $318 - $561	-476 Reduced 0.94%	50,108 $34.9 Million
Q3 2024 Nov 15, 2024	SELL	$0.81 - $1.45 $477 - $854	-589 Reduced 1.15%	50,584 $46.8 Million
Q2 2024 Jul 24, 2024	SELL	$0.43 - $1.01 $1,774 - $4,168	-4,127 Reduced 7.46%	51,173 $46.1 Million
Q1 2024 May 13, 2024	BUY	$0.42 - $0.61 $4,966 - $7,212	11,824 Added 27.2%	55,300 $34.4 Million
Q4 2023 Feb 05, 2024	BUY	$0.55 - $0.85 $8,252 - $12,753	15,004 Added 52.7%	43,476 $22.9 Million
Q3 2023 Nov 14, 2023	BUY	$0.6 - $0.82 $17,083 - $23,347	28,472 New	28,472 $16.2 Million

Others Institutions Holding TLSA

# of Institutions

Shares Held

993K

Call Options Held

Put Options Held

View Full List

About Tiziana Life Sciences Ltd

Ticker TLSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,273,000
Market Cap $146M
Description
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...

More about TLSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.

Account